Liberty Health Sciences Gives 2018 Sales Update

Cannabis Investing News

Liberty Health Sciences gave investors an updated look at their monthly revenue so far in 2018.

Liberty Health Sciences (CSE:LHS; OTCQX:LHSIF) gave investors an updated look at their monthly sales revenue so far in 2018.

As quoted in the press release:

Liberty Health Sciences (“Liberty” or the “Company“) today announced that the Company has recorded a 253 [percent] increase in monthly revenue since the start of 2018, and a 100 [percent] increase in its served patient count. The surge has been fueled by unprecedented growth in the number of registered medical cannabis patients and physicians in the state of Florida. So far this year, the number of registered patients in Florida has increased 46 [percent] to over 93,000 patients, and the number of recommending physicians has increased 44 [percent] as the physician community continues to witness the benefits of medical cannabis first-hand.

“The growth in registered medical cannabis patients in Florida is far exceeding our expectations, but Liberty is fully prepared to meet the rapidly expanding demand with our production expansion currently underway at Chestnut Hill and Liberty 360 facilities and our new southern Florida distribution hub,” said [George Scorsis, director and CEO of Liberty]. “We are committed to providing all of our patients across Florida with fast and convenient access to medical cannabis, regardless of their location in the state.”

Click here to read the full press release.

Source: www.newswire.ca

The Conversation (0)
×